A detailed history of Whittier Trust CO transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Whittier Trust CO holds 323 shares of EDIT stock, worth $403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
323
Previous 323 -0.0%
Holding current value
$403
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$4.67 - $7.28 $116 - $182
25 Added 8.39%
323 $1,000
Q2 2018

Jul 27, 2018

BUY
$31.4 - $41.01 $9,357 - $12,220
298 New
298 $11,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $85.9M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.